Latest filing published 27 Jan 2023 for MITHRA PHARMACEUTICALS, €618k.
Insider track record
Noshaq SA: trading record in brief
Noshaq SA is a declared insider of Mithra Pharmaceuticals, with filings sourced from FSMA. The record holds 8 filings, for trades running from 1 July 2021 to 17 January 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 27 January 2023: a transaction of €618k, in Mithra Pharmaceuticals. Typically, a trade is published a median of 10 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Noshaq SA
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 172,574 shares@ €3.584.5% of flowShareEuronext BrusselsISIN BE0974283153FSMA:mithra-pharmaceuticals-23
- 172,574 shares@ €6.107.7% of flowShareEuronext BrusselsISIN BE0974283153FSMA:mithra-pharmaceuticals-56
- 156,250 shares@ €6.447.4% of flowShareEuronext BrusselsISIN BE0974283153FSMA:mithra-pharmaceuticals-15
- 156,250 shares@ €7.939.1% of flowShareEuronext BrusselsISIN BE0974283153FSMA:mithra-pharmaceuticals-37
- 110,548 shares@ €21.7017.6% of flowShareOff exchangeISIN BE0974283153FSMA:mithra-pharmaceuticals-50
- 110,548 shares@ €21.7017.6% of flowShareOff exchangeISIN BE0974283153FSMA:mithra-pharmaceuticals-63
- 107,101 shares@ €22.9018.0% of flowShareOff exchangeISIN BE0974283153FSMA:mithra-pharmaceuticals-9
- 107,101 shares@ €22.9018.0% of flowShareEuronext BrusselsISIN BE0974283153FSMA:mithra-pharmaceuticals-13
8 of 8 declarations